Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Protocol of trans-Tasman feasibility randomised controlled trial of the Younger Women's Wellness After Breast Cancer (YWWACP) lifestyle intervention.
Sharples K, Vear NK, Porter-Steele J, Anderson DJ, Moeke-Maxwell TH, Laing BB, Young L, Bailey TG, Benge S, Huang Y, Crowley E, Day R, Cartwright R, Findlay M, Porter D, Kuper M, Campbell I, McCarthy AL. Sharples K, et al. Among authors: findlay m. Pilot Feasibility Stud. 2022 Aug 2;8(1):165. doi: 10.1186/s40814-022-01114-z. Pilot Feasibility Stud. 2022. PMID: 35918737 Free PMC article.
A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II.
Harvey VJ, Sharples KJ, Isaacs RJ, Jameson MB, Jeffery GM, McLaren BR, Pollard S, Riley GA, Simpson AB, Hinder VA, Scott JN, Dzhelali MV, Findlay MP. Harvey VJ, et al. Among authors: findlay mp. Ann Oncol. 2013 Jul;24(7):1828-1834. doi: 10.1093/annonc/mdt065. Epub 2013 Mar 4. Ann Oncol. 2013. PMID: 23463624 Free article. Clinical Trial.
A randomised phase IIb trial to assess the efficacy of ReCharge ice cream in preventing chemotherapy-induced diarrhoea.
Perez D, Sharples KJ, Broom R, Jeffery M, Proctor J, Hinder V, Pollard S, Edwards J, Simpson A, Scott J, Benge S, Krissansen G, Geursen A, Palmano K, MacGibbon A, Keefe D, Findlay M. Perez D, et al. Among authors: findlay m. Support Care Cancer. 2015 Nov;23(11):3307-15. doi: 10.1007/s00520-015-2755-0. Epub 2015 May 28. Support Care Cancer. 2015. PMID: 26018599 Clinical Trial.
High CYP2C19 phenotypic variability in gastrointestinal cancer patients.
Burns KE, Lo WY, Findlay MP, Sharples K, Laking G, Helsby NA. Burns KE, et al. Among authors: findlay mp. Cancer Chemother Pharmacol. 2016 Jan;77(1):195-204. doi: 10.1007/s00280-015-2923-4. Epub 2015 Nov 27. Cancer Chemother Pharmacol. 2016. PMID: 26614509
A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma.
Dasyam N, Sharples KJ, Barrow C, Huang Y, Bauer E, Mester B, Wood CE, Authier-Hall A, Dzhelali M, Ostapowicz T, Kumar R, Lowe J, Maxwell A, Burn OK, Williams GM, Carley SE, Caygill G, Jones J, Chan STS, Hinder VA, Macapagal J, McCusker M, Weinkove R, Brimble MA, Painter GF, Findlay MP, Dunbar PR, Gasser O, Hermans IF. Dasyam N, et al. Among authors: findlay mp. Cancer Immunol Immunother. 2023 Jul;72(7):2267-2282. doi: 10.1007/s00262-023-03400-y. Epub 2023 Mar 7. Cancer Immunol Immunother. 2023. PMID: 36881133 Free PMC article. Clinical Trial.
284 results